Contact PD/PI: Dubinett, Steven M. OVERALL PROJECT SUMMARY/ABSTRACT The UCLA Clinical and Translational Science Institute is a research partnership of UCLA-Westwood, Cedars- Sinai Medical Center, Charles R. Drew University of Medicine and Science and the Los Angeles Biomedical Institute at Harbor UCLA Medical Center. Its mission is to bring biomedical innovations to bear on the greatest health needs of Los Angeles?the largest and one of the most ethnically, socially and economically diverse counties in the United States. In doing so, our goal is to become a leading contributor in the CTSA Consortium and speed scientific translation to benefit the nation as a whole. The CTSI has five aims: (1) Prepare the translational workforce to conduct high-quality, multidisciplinary team science; (2) Engage stakeholder communities in clinical and translational research and disseminate successful models of collaboration; (3) Integrate special populations, especially those experiencing health disparities, into research; (4) Improve methods and processes to accelerate scientific translation, overcome key roadblocks and support multisite research; (5) Provide informatics solutions to operational and scientific roadblocks to advance high-impact translational science within the UCLA CTSI and the CTSA network. Our novel infrastructure includes: The Los Angeles Data Resource (LADR), a federation of clinical data warehouses from six Los Angeles institutions; its governance agreement serves as the model for the CTSA ACT initiative; an Innovation and Implementation Core with Los Angeles County, a laboratory for testing approaches for improving care for the nearly 700,000 people annually treated in the county health system; a Precision Medicine program that forms the infrastructure to bring genomic-level diagnosis to translational investigation and clinical care across our UCLA Hub, multiple CTSAs and partner institutions; a training program that integrates entrepreneurship principles in on-the-job training experiences in which investigators are guided to utilize their own findings as they bring their discoveries to products. We propose to transform our CTSI from a high-functioning service organization into a well-integrated research accelerator that will develop, demonstrate and disseminate novel solutions to translational roadblocks, to the ultimate benefit of the Los Angeles community, our region and the nation. Project Summary/Abstract Page 745 Contact PD/PI: Dubinett, Steven M. OVERALL

Public Health Relevance

Residents of Los Angeles County are disproportionately young, poor and sick. Nearly one in three is under age 18 and one in five is below the federal poverty line. One in four lacks health insurance. Rates of premature death and disability far exceed national averages. The disease burden is magnified by language barriers, cultural beliefs, poverty and disparities in access to care. The goal of this work is to bring biomedical innovations to bear on the greatest health needs of Los Angeles?the largest and one of the most ethnically, socially and economically diverse counties in the United States. Project Narrative Page 746

Agency
National Institute of Health (NIH)
Institute
National Center for Advancing Translational Sciences (NCATS)
Type
Linked Specialized Center Cooperative Agreement (UL1)
Project #
5UL1TR001881-03
Application #
9515094
Study Section
Special Emphasis Panel (ZTR1)
Program Officer
Talbot, Bernard
Project Start
2016-07-01
Project End
2021-05-31
Budget Start
2018-06-01
Budget End
2019-05-31
Support Year
3
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Jiang, Jiansen; Wang, Yaqiang; SuĊĦac, Lukas et al. (2018) Structure of Telomerase with Telomeric DNA. Cell 173:1179-1190.e13
Malik, Rainer (see original citation for additional authors) (2018) Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes. Nat Genet 50:524-537
Schwartz, Steven; Bazargan-Hejazi, Shahrzad; Pan, Deyu et al. (2018) Association of Psychiatric Diagnostic Conditions with Hospital Care Outcomes of Patients with Orthopedic Injuries. Perm J 22:
Brown, Arleen F; Liang, Li-Jung; Vassar, Stefanie D et al. (2018) Trends in Racial/Ethnic and Nativity Disparities in Cardiovascular Health Among Adults Without Prevalent Cardiovascular Disease in the United States, 1988 to 2014. Ann Intern Med 168:541-549
Zhang, Yulong; Zheng, Zhong; Yu, Mengliu et al. (2018) Using an Engineered Galvanic Redox System to Generate Positive Surface Potentials that Promote Osteogenic Functions. ACS Appl Mater Interfaces 10:15449-15460
Gao, Chuan; Tabb, Keri L; Dimitrov, Latchezar M et al. (2018) Exome Sequencing Identifies Genetic Variants Associated with Circulating Lipid Levels in Mexican Americans: The Insulin Resistance Atherosclerosis Family Study (IRASFS). Sci Rep 8:5603
Ranganath, Veena K; Duffy, Erin L; Garg, Vikram K et al. (2018) Obesity Impacts Swelling of Ankle and Foot Joints in Early Rheumatoid Arthritis Patients. J Clin Rheumatol :
Emdin, Connor A; Khera, Amit V; Chaffin, Mark et al. (2018) Analysis of predicted loss-of-function variants in UK Biobank identifies variants protective for disease. Nat Commun 9:1613
Minissian, Margo B; Kilpatrick, Sarah; Eastwood, Jo-Ann et al. (2018) Association of Spontaneous Preterm Delivery and Future Maternal Cardiovascular Disease. Circulation 137:865-871
Kim, Se-Min; Cui, Jinrui; Rhyu, Jane et al. (2018) Association between site-specific bone mineral density and glucose homeostasis and anthropometric traits in healthy men and women. Clin Endocrinol (Oxf) 88:848-855

Showing the most recent 10 out of 287 publications